The study of nearly 28,000 23AndMe users who reported taking the weight-loss drugs found that a mutation in GLP1R, the gene for the protein targeted by GLP-1 drugs, is modestly but significantly associated with increased efficacy of the medications, researchers reported in Nature
Victoza (liraglutide) Drug class: GLP-1 Agonists What is Victoza
It makes sure the benefits of the first treatment last longer
This is why insulin, growth hormone, and many other peptide-based medications require injection-oral administration would result in degradation before the compound reaches systemic circulation
Patients who take Ozempic should have regular follow-ups with their doctors and share any symptoms or side effects they may be experiencing
Weight loss : Retatrutide showed 28.7% at 68 weeks (Phase 3 TRIUMPH-4) versus CagriSema's 20.4% at 68 weeks (Phase 3 REDEFINE 1), though cross-trial comparisons are limited